Pfizer Ltd
Pfizer Ltd (PFIZER) last traded at ₹4,761, a market capitalisation of ₹21,781 crore, on a P/E of 28.3. Over the past 52 weeks the stock has ranged between ₹4,360 and ₹5,578. Pfizer Ltd last reported results for the quarter ended Jun 2026, with sales of ₹653 crore and net profit of ₹204 crore. Figures are as of 25 Aug 2026 and are not real time.
Pfizer Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Pfizer Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹653 cr, up 8.3% from ₹603 cr a year earlier. Net profit was ₹204 cr, up 6.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 589 | 538 | 592 | 603 | 642 | 645 | 629 | 653 |
| Expenses | 399 | 392 | 364 | 393 | 412 | 417 | 393 | 406 |
| Operating profit | 189 | 146 | 228 | 210 | 230 | 228 | 236 | 248 |
| OPM % | 32% | 27% | 38% | 35% | 36% | 35% | 38% | 38% |
| Other income | 43 | 43 | 217 | 67 | 42 | -20 | 50 | 45 |
| Interest | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 1 |
| Depreciation | 15 | 15 | 16 | 14 | 14 | 14 | 15 | 14 |
| Profit before tax | 215 | 172 | 426 | 260 | 255 | 192 | 269 | 277 |
| Tax % | 26% | 26% | 22% | 26% | 26% | 26% | 26% | 26% |
| Net profit | 158 | 128 | 331 | 192 | 189 | 142 | 200 | 204 |
| EPS (₹) | 34.61 | 27.89 | 72.34 | 41.91 | 41.32 | 31.00 | 43.68 | 44.70 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Pfizer Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 2,239 | 2,611 | 2,425 | 2,193 | 2,281 | 2,520 | 2,570 |
| Operating profit | 712 | 836 | 809 | 638 | 742 | 904 | 942 |
| OPM % | 32% | 32% | 33% | 29% | 33% | 36% | 37% |
| Net profit | 498 | 613 | 624 | 551 | 768 | 722 | 735 |
| EPS (₹) | 108.77 | 133.90 | 136.38 | 120.52 | 167.79 | 157.92 | 160.70 |
TTM is the trailing twelve months to the most recent quarter.
Pfizer Ltd growth and returns
- 10 Years
- 2%
- 5 Years
- 2%
- 3 Years
- 1%
- TTM
- 11%
- 10 Years
- 10%
- 5 Years
- 9%
- 3 Years
- 8%
- TTM
- 14%
- 10 Years
- 10%
- 5 Years
- -3%
- 3 Years
- 8%
- 1 Year
- -11%
- 10 Years
- 17%
- 5 Years
- 18%
- 3 Years
- 16%
- Last Year
- 18%
Pfizer Ltd shareholding pattern
Promoters held 63.92% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.65% and DIIs 17.80%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% | 63.92% |
| FIIs | 3.54% | 2.74% | 2.18% | 2.40% | 2.60% | 2.71% | 2.81% | 1.65% |
| DIIs | 16.03% | 16.80% | 17.10% | 17.23% | 17.11% | 17.05% | 16.89% | 17.80% |
| Public | 16.50% | 16.54% | 16.79% | 16.45% | 16.37% | 16.32% | 16.36% | 16.62% |
| No. of shareholders | 98,824 | 1,05,015 | 1,08,261 | 1,03,222 | 1,03,480 | 1,00,933 | 99,545 | 1,02,478 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Pfizer Ltd corporate filings
- Newspaper Advertisement - Special Window for Re- lodgement of Transfer and Dematerialisation of Physical Securities.Company Updatelow impact
Cruxal's analysis: Pfizer Ltd has published a newspaper advertisement on August 4, 2026, announcing a…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Pfizer Ltd
Cruxal reads every Pfizer Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.